BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hlebokazov F, Dakukina T, Ihnatsenko S, Kosmacheva S, Potapnev M, Shakhbazau A, Goncharova N, Makhrov M, Korolevich P, Misyuk N, Dakukina V, Shamruk I, Slobina E, Marchuk S. Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: An open label study. Adv Med Sci 2017;62:273-9. [PMID: 28500900 DOI: 10.1016/j.advms.2016.12.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Shaimardanova AA, Chulpanova DS, Mullagulova AI, Afawi Z, Gamirova RG, Solovyeva VV, Rizvanov AA. Gene and Cell Therapy for Epilepsy: A Mini Review. Front Mol Neurosci 2022;15:868531. [DOI: 10.3389/fnmol.2022.868531] [Reference Citation Analysis]
2 Mazini L, Rochette L, Amine M, Malka G. Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). Int J Mol Sci. 2019;20:2523. [PMID: 31121953 DOI: 10.3390/ijms20102523] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 28.7] [Reference Citation Analysis]
3 Forsberg MH, Kink JA, Hematti P, Capitini CM. Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol 2020;8:665. [PMID: 32766255 DOI: 10.3389/fcell.2020.00665] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
4 Aligholi H, Safahani M, Asadi-Pooya AA. Stem cell therapy in patients with epilepsy: A systematic review. Clin Neurol Neurosurg 2021;200:106416. [PMID: 33338823 DOI: 10.1016/j.clineuro.2020.106416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hlebokazov F, Dakukina T, Potapnev M, Kosmacheva S, Moroz L, Misiuk N, Golubeva T, Slobina E, Krasko O, Shakhbazau A, Hlavinski I, Goncharova N. Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients. Clin Neurol Neurosurg 2021;207:106736. [PMID: 34119901 DOI: 10.1016/j.clineuro.2021.106736] [Reference Citation Analysis]
6 Barros I, Silva A, de Almeida LP, Miranda CO. Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy. Cytokine Growth Factor Rev 2021;58:114-33. [PMID: 33397585 DOI: 10.1016/j.cytogfr.2020.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhao H, Li S, He L, Tang F, Han X, Deng W, Lin Z, Huang R, Li Z. Ameliorating Effect of Umbilical Cord Mesenchymal Stem Cells in a Human Induced Pluripotent Stem Cell Model of Dravet Syndrome. Mol Neurobiol 2021. [PMID: 34766239 DOI: 10.1007/s12035-021-02633-1] [Reference Citation Analysis]
8 Gupta A, Orchard PJ, Miller WP, Nascene DR, Raymond GV, Loes DJ, McKenna DH, Lund TC. Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy. Stem Cells Transl Med 2020;9:554-8. [PMID: 32020747 DOI: 10.1002/sctm.19-0304] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Cavarsan CF, Malheiros J, Hamani C, Najm I, Covolan L. Is Mossy Fiber Sprouting a Potential Therapeutic Target for Epilepsy? Front Neurol 2018;9:1023. [PMID: 30555406 DOI: 10.3389/fneur.2018.01023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
10 Andrejew R, Glaser T, Oliveira-Giacomelli Á, Ribeiro D, Godoy M, Granato A, Ulrich H. Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases. Adv Exp Med Biol 2019;1201:275-353. [PMID: 31898792 DOI: 10.1007/978-3-030-31206-0_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yan HS, Hang C, Chen SW, Wang KK, Bo P. Salvianolic acid B combined with mesenchymal stem cells contributes to nucleus pulposus regeneration. Connect Tissue Res 2020;61:435-44. [PMID: 31023105 DOI: 10.1080/03008207.2019.1611794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sadanandan N, Saft M, Gonzales-Portillo B, Borlongan CV. Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy. Front Pharmacol 2021;12:596287. [PMID: 33815100 DOI: 10.3389/fphar.2021.596287] [Reference Citation Analysis]
13 Caplan H, Olson SD, Kumar A, George M, Prabhakara KS, Wenzel P, Bedi S, Toledano-Furman NE, Triolo F, Kamhieh-Milz J, Moll G, Cox CS Jr. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front Immunol 2019;10:1645. [PMID: 31417542 DOI: 10.3389/fimmu.2019.01645] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 28.0] [Reference Citation Analysis]
14 Badyra B, Sułkowski M, Milczarek O, Majka M. Mesenchymal stem cells as a multimodal treatment for nervous system diseases. Stem Cells Transl Med 2020;9:1174-89. [PMID: 32573961 DOI: 10.1002/sctm.19-0430] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, Bronisz A, Revai Lechtich E, Sasaki H, Mora JL, Brastianos PK, Falcone JL, Hofer AM, Franco A, Shah K. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv 2021;7:eabe8671. [PMID: 33658202 DOI: 10.1126/sciadv.abe8671] [Reference Citation Analysis]
16 Gala D, Gurusamy V, Patel K, Damodar S, Swaminath G, Ullal G. Stem Cell Therapy for Post-Traumatic Stress Disorder: A Novel Therapeutic Approach. Diseases 2021;9:77. [PMID: 34842629 DOI: 10.3390/diseases9040077] [Reference Citation Analysis]
17 Szczepanik E, Mierzewska H, Antczak-Marach D, Figiel-Dabrowska A, Terczynska I, Tryfon J, Krzesniak N, Noszczyk BH, Sawicka E, Domanska-Janik K, Sarnowska A. Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy. Stem Cells Int 2020;2020:7104243. [PMID: 32190059 DOI: 10.1155/2020/7104243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Asadi-Pooya AA, Bartolini L. Prevention and treatment of temporal lobe epilepsy: lessons from hepatitis B story! Int J Neurosci 2020;130:1151-5. [PMID: 32053411 DOI: 10.1080/00207454.2020.1730370] [Reference Citation Analysis]
19 Pan K, Deng L, Chen P, Peng Q, Pan J, Wu Y, Wang Y. Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases. Stem Cells Int 2019;2019:8421281. [PMID: 31428161 DOI: 10.1155/2019/8421281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]